Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0002055 Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
2017/0002054 Methods for Identifying and Isolating Cells Expressing a Polypeptide
The invention relates to novel polypeptides and cells comprising the polypeptides. The polypeptides and cells are used in methods to identify and/or isolate...
2017/0002053 METHODS OF MODULATING COLD SENSORY PERCEPTION
The present invention relates to regulation of cold sensation and pain. More particularly, the present invention is directed to nucleic acids encoding a member...
2017/0002052 Method of Production of Human Insulin Methyl Ester
The present invention relates to production of Human Insulin methyl ester by enzymatic reaction. The present invention further relates to production and...
2017/0002051 AVIAN COLONY STIMULATING FACTOR 1 RECEPTOR BINDING PROTEINS
The present invention provides avian CSF1 genes encoding proteins which bind avian colony stimulating factor 1 receptor (CSF1R) and which exhibit ...
2017/0002050 EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE
EphA2 T-cell epitope are provided herein. The epitopes include peptides corresponding to specific fragments of human EphA2 protein containing one or more...
2017/0002049 COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
The invention provides peptides and analogs of INGAP and HIP peptides. The peptides and analogs can be used in methods for treating various diseases and...
2017/0002048 METHOD FOR PURIFYING AND RENATURATING INCLUSION BODIES OF SCORPION TOXIN PROTEIN AND THEIR USE
A method for purifying and renaturating inclusion bodies of scorpion venom protein is provided. The method includes expressing the scorpion venom protein by...
2017/0002047 PLANT-DERIVED ELASTIN BINDING PROTEIN LIGANDS AND METHODS OF USING THE SAME
The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and...
2017/0002046 PROTEINS COMPRISING BINDING REGIONS, SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS, AND CARBOXY-TERMINAL, ENDOPLASMIC...
The present invention provides proteins comprising binding regions for cell-type specific targeting, Shiga toxin effector regions derived from A Subunits of...
2017/0002045 PLASMID, METHOD AND KIT THEREOF FOR PRODUCING HEAT LABILE ENTEROTOXIN B-SUBUNIT
The present invention provides a plasmid, method and kit for producing heat labile enterotoxin B-subunit based on a Bacillus subtilis expression system. By...
2017/0002044 Production of Polypeptides Relevant to Human and Animal Health Using Yarrowia lipolytica
The present invention relates to the expression of polypeptides using Yarrowia lipolytica, in particular the secretion of expressed polypeptides into either...
2017/0002043 NOVEL PEPTIDES AND METHODS AND USES THEREOF FOR PREVENTING RETINAL DISORDERS
The present disclosure relates to methods and uses of C-terminal peptides for inhibiting neuronal cell death or dysfunction, such as retinal ganglion cell...
2017/0002042 PEPTIDOMIMETIC MACROCYCLES
The present invention provides novel peptidomimetic macrocycles and methods of using such macrocycles for the treatment of viral disease.
2017/0002041 NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES
The present invention relates to hydrophobic peptides and/or peptidomimetics capable of forming a (nanofibrous) hydrogel and hydrogels comprising said...
2017/0002040 NOVEL THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA
The present invention provides benzothiadiazine and chroman derivatives and particularly diazoxide and cromakalim derivatives for use in treating glaucoma,...
2017/0002039 A Pentacyclic Triterpenoid Compound with Modified Structure and Preparation Method and Use Thereof
The present invention relates to new pentacyclic triterpenes, their preparation method and use. The compounds of the present invention could effectively treat...
2017/0002038 METHOD OF CUTTING OUT RNA OLIGONUCLEOTIDE
The invention provides a cut-out method capable of suppressing production of a byproduct, wherein the object RNA oligonucleotide is not cleaved from a...
2017/0002037 CYCLIC NUCLEOTIDE ANALOGS
Disclosed herein are cyclic nucleotide analogs, methods of synthesizing cyclic nucleotide analogs and methods of treating diseases and/or conditions such as...
2017/0002036 CRYSTAL FORM OF REGADENOSON AND PREPARATION METHOD THEREOF
The present invention relates to the field of medicinal chemistry, and discloses a new crystal form of regadenoson, i.e., a crystal form E of regadenoson, as...
2017/0002035 NOVEL CRYSTALLINE FORMS OF AN ANTIVIRAL BENZIMIDAZOLE COMPOUND
The invention relates to crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-.beta.-L-ribofuranosyl-1Hbenzimidazole, pharmaceutical compositions comprising...
2017/0002034 COMPOSITIONS AND METHODS FOR IMPROVING REBAUDIOSIDE X SOLUBILITY
Polymorphic and amorphous forms of Rebaudioside X and methods for preparing the same are provided herein. Also provided herein are Rebaudioside X complexes and...
2017/0002033 ACYCLIC NUCLEOSIDE PHOSPHONATE DIESTERS
The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and...
2017/0002032 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
Disclosed are chemical entities which are compounds of formula (I): ##STR00001## or pharmaceutically acceptable salts thereof; wherein Y, R.sup.a, R.sup.a',...
2017/0002031 Echothiophate Iodide Process
The present invention relates to a process for preparation of Echothiophate Iodide (I). Echothiophate Iodide (I) obtained by the process of the present...
2017/0002030 AMINO-CONTAINING ORGANOSILICON COMPOUND AND MAKING METHOD
An amino-containing organosilicon compound having formula (1) is used for surface treatment of an inorganic filler for thereby rendering the filler more...
2017/0002029 TRIS(TRIMETHYL SILOXY)SILANE VINYLIC MONOMERS AND USES THEREOF
The invention provides a TRIS-containing vinylic monomer which comprises one sole (meth)acryloyloxy group and a tris(trimethylsiloxy)silyl group covalently...
2017/0002028 SILICON PHTHALOCYANINE COMPLEX, PREPARATION METHOD AND MEDICINAL APPLICATION THEREOF
The present invention relates to a silicon phthalocyanine complex, the preparation method and the medicinal application thereof. The present invention...
2017/0002027 Transition Metal Complexes of Tridentate Dianionic CNN Ligands, Production and Use Thereof
New pyridylamide transition metal complex compositions for olefin polymerizations are described herein featuring a 7-membered chelate ring and a cyclometalated...
2017/0002026 System for Controlling the Reactivity of Boronic Acids
A protected organoboronic acid includes a boron having an sp.sup.3 hybridization, a conformationally rigid protecting group bonded to the boron, and an organic...
2017/0002025 CYCLIZED SULFAMOYLARYLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
Inhibitors of HBV replication of Formula (I-A) ##STR00001## including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R.sup.a to...
2017/0002024 BENZOTHIADIAZOLE-BASED CONJUGATED MOLECULES CAPABLE OF FORMING FILMS ON CONDUCTIVE SURFACES BY ELECTROCHEMICAL...
The present disclosure provides new materials that combine the advantages of well-defined polymeric starting materials and the convenience of surface...
2017/0002023 DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES
The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including...
2017/0002022 BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE
Described herein are benzoxazepin oxazolidinone compounds with phosphoinositide-3 kinase (PI3K) modulation activity or function having the Formula I...
2017/0002021 BENZOXAZINONE DERIVATIVES FOR TREATMENT OF SKIN DISEASES
The present invention relates to methods and compositions for inhibiting the activity of skin proteases, especially human kallikrein 7 (KLK7), human kallikrein...
2017/0002020 NEW DIHYDRO-OXAZINOBENZODIAZEPINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITONS...
Compounds of formula (I) ##STR00001## having a selective dual action on the central GABAergic system, and a process for their preparation and to pharmaceutical...
2017/0002019 SYNTHESIS OF ISOHEXIDE ETHERS AND CARBONATES
A facile, straightforward method for alkylation of anhydrosugar alcohols (isohexides) using a carbonate reagent is described. The alkylation method involves:...
2017/0002018 ENHANCED REGIO-SELECTIVITY IN GLYCOL ACYLATION
A method for acid-catalyzed acylation of an isohexide is described. The method involves a reaction of an isohexide and an excess of carboxylic acid in the...
2017/0002017 N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
The invention provides novel compounds having the general formula: ##STR00001## and pharmaceutically acceptable salts thereof, wherein the variables R.sup.A,...
2017/0002016 AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS
The present invention relates to azaspiro derivatives of the formula (I) or a pharmaceutically acceptable salt thereof or a prodrug thereof, processes for...
2017/0002015 CYCLOPROPYL MODULATORS OF P2Y12 RECEPTOR
The present invention relates to new cyclopropyl modulators of P2Y12 receptor activity, pharmaceutical compositions thereof, and methods of use thereof. ...
2017/0002014 SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS
The present invention provides protein kinase having one of the following structures (I), (II) or (III): ##STR00001## or a stereoisomer, prodrug, tautomer or...
2017/0002013 SUBSTITUTED 4-METHYL-PYRROLO[1,2-A]PYRIMIDINE-8-CARBOXAMIDE COMPOUNDS AND USES THEREOF FOR MODULATING...
Disclosed are new small molecules having a 4-methylpyrrrolo[1,2-a]pyrimidine-8-carboxamide core structure and the uses thereof for modulating...
2017/0002012 PROCESS FOR THE CYCLOADDITION OF A HETERO(ARYL) 1,3-DIPOLE COMPOUND WITH A (HETERO)CYCLOALKYNE
A process is provided, comprising reacting a (hetero)aryl 1,3-dipole compound with a (hetero)cycloalkyne, wherein the (hetero)aryl 1,3-dipole compound...
2017/0002011 BENZENE SULFONAMIDES AS CCR9 INHIBITORS
The present invention relates to compounds useful as CCR9 modulators, to compositions containing them, to methods of making them, and to methods of using them....
2017/0002010 IMIDAZOPYRAZINONE DERIVATIVES
Compounds of the formula I ##STR00001## in which R.sup.1 and R.sup.2 have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed,...
2017/0002009 CRYSTALLINE FORM I OF IBRUTINIB
Crystalline Form I of ibrutinib, processes for its preparation, pharmaceutical compositions comprising the new Form, and use of Form I of ibrutinib for...
2017/0002008 BICYCLOAMINE-SUBSTITUTED-N-BENZENESULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS
Disclosed are compounds of Formula A-a, or a salt thereof: Where "B.sup.1" and "R.sup.1" through "R.sup.5" are as defined herein, which compounds have...
2017/0002007 A3 ADENOSINE RECEPTOR AGONISTS
Disclosed are compounds of the formula (I) and (II) which are A3 adenosine receptor agonists, pharmaceutical compositions comprising such compounds, and a...
2017/0002006 MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.